» Articles » PMID: 32063749

Construction of a CircRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA Reveals the Function of CircRNAs in Osteosarcoma

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2020 Feb 18
PMID 32063749
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteosarcoma (OS) is a common primary malignant bone tumour. Growing evidence suggests that circular RNAs (circRNAs) are closely related to the development of tumours. However, the function of circRNAs in OS remains unknown. Here, we aimed to determine the regulatory mechanisms of circRNAs in OS.

Methods: The expression profiles of OS circRNA (GSE96964), microRNA (GSE65071) and mRNA (GSE33382) were downloaded from the Gene Expression Omnibus (GEO) database to identify differentially expressed circRNAs, miRNAs and mRNAs in OS. A ceRNA network was constructed based on circRNA-miRNA pairs and miRNA-mRNA pairs. MRNAs with significant prognostic differences were identified by the TARGET database in the network. Functional and pathway enrichment analyses were performed, and interactions between proteins were predicted using Cytoscape. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to elucidate the possible functions of these differentially expressed circRNAs.

Results: A total of 15 downregulated circRNAs, 136 upregulated miRNAs and 52 downregulated mRNAs were identified in OS. Finally, a circRNA-miRNA-mRNA network was constructed in OS based on 14 circRNAs, 24 miRNAs, and 52 mRNAs. GO and KEGG pathway analyses suggested that the mRNAs in the network may be involved in the pathogenesis and progression of OS. Four mRNAs identified by the TARGET database were significantly associated with OS survival prognosis. A circRNA-miRNA-mRNA subnetwork was constructed based on these four mRNAs.

Conclusion: Our results provide a deeper understanding of the regulatory mechanisms by which circRNAs compete for endogenous RNAs in OS.

Citing Articles

Circ_0049271 targets the miR-1197/PTRF axis to attenuate the malignancy of osteosarcoma.

Wen Y, Xu F, Zhang H Cancer Biomark. 2024; 40(2):141-153.

PMID: 38578882 PMC: 11321495. DOI: 10.3233/CBM-230191.


Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research.

Chen L, He L, Liu B, Zhou Y, Lv L, Wang Z Front Oncol. 2024; 14:1255061.

PMID: 38532928 PMC: 10964489. DOI: 10.3389/fonc.2024.1255061.


Circ_0004872 deficiency attenuates ox-LDL-induced vascular smooth muscle cell dysfunction by miR-424-5p-dependent regulation of FRS2.

Qian P, Cao X, Zhang Q, Gao M, Liu X, Yan L Mol Cell Biochem. 2024; 479(12):3425-3435.

PMID: 38376663 DOI: 10.1007/s11010-024-04929-x.


Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer.

Huang Z, Yao H, Yang Z Oncol Lett. 2023; 26(4):448.

PMID: 37720676 PMC: 10502932. DOI: 10.3892/ol.2023.14035.


Cellular and Genetic Background of Osteosarcoma.

Urlic I, Jovicic M, Ostojic K, Ivkovic A Curr Issues Mol Biol. 2023; 45(5):4344-4358.

PMID: 37232745 PMC: 10217763. DOI: 10.3390/cimb45050276.


References
1.
Min X, Heng H, Yu H, Dan M, Jie C, Zeng Y . Anticancer effects of 10-hydroxycamptothecin induce apoptosis of human osteosarcoma through activating caspase-3, p53 and cytochrome pathways. Oncol Lett. 2018; 15(2):2459-2464. PMC: 5777291. DOI: 10.3892/ol.2017.7610. View

2.
Ma C, Zhang Z, Cui Y, Yuan H, Wang F . Silencing FAT10 inhibits metastasis of osteosarcoma. Int J Oncol. 2016; 49(2):666-74. DOI: 10.3892/ijo.2016.3549. View

3.
Jiang X, Li Z, Li J, Xu Y, Leng K, Cui Y . A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as. Eur Rev Med Pharmacol Sci. 2018; 22(2):365-371. DOI: 10.26355/eurrev_201801_14182. View

4.
Patop I, Kadener S . circRNAs in Cancer. Curr Opin Genet Dev. 2017; 48:121-127. PMC: 5877416. DOI: 10.1016/j.gde.2017.11.007. View

5.
Wang G, Chen J, Qiang Y, Wang D, Chen Z . Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. World J Gastroenterol. 2015; 21(13):3983-93. PMC: 4385547. DOI: 10.3748/wjg.v21.i13.3983. View